Curated Resources — Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Featured analysis

Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri — Background & Analysis

In-depth context and analysis on this topic for researchers and advocates.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.